Application Nr Approved Date Route Status External Links
NDA211172 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Tegsedi Is Indicated For The Treatment Of The Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis In Adults. Tegsedi Is A Transthyretin-Directed Antisense Oligonucleotide Indicated For Treatment Of The Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis In Adults ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Inotersen Sodium

Comments